AIG
ADMA icon

American International Group’s ADMA Biologics ADMA Stock Holding History

American International Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-105,057
Closed -$693K – 48
2024
Q1 		$693K Sell
105,057
-902
-0.9% -$4.93K ﹤0.01% 1495
2023
Q4 		$479K Buy
105,959
+829
+0.8% +$3.07K ﹤0.01% 1685
2023
Q3 		$376K Buy
105,130
+3,738
+4% +$14.4K ﹤0.01% 1769
2023
Q2 		$374K Buy
101,392
+344
+0.3% +$1.27K ﹤0.01% 1823
2023
Q1 		$334K Buy
101,048
+13,135
+15% +$45.4K ﹤0.01% 1825
2022
Q4 		$341K Sell
87,913
-321
-0.4% -$990 ﹤0.01% 1815
2022
Q3 		$214K Buy
88,234
+1,247
+1% +$2.99K ﹤0.01% 2116
2022
Q2 		$172K Buy
+86,987
New +$171K ﹤0.01% 2286
2021
Q2 		– Sell
-38,412
Closed -$68K – 3104
2021
Q1 		$68K Buy
38,412
+101
+0.3% +$231 ﹤0.01% 2887
2020
Q4 		$75K Buy
38,311
+2,320
+6% +$4.88K ﹤0.01% 2791
2020
Q3 		$86K Sell
35,991
-819
-2% -$2.25K ﹤0.01% 2603
2020
Q2 		$108K Sell
36,810
-4,789
-12% -$13.8K ﹤0.01% 2491
2020
Q1 		$120K Buy
41,599
+10,083
+32% +$34.9K ﹤0.01% 2203
2019
Q4 		$126K Sell
31,516
-265
-0.8% -$1.16K ﹤0.01% 2488
2019
Q3 		$141K Buy
31,781
+14,396
+83% +$60.2K ﹤0.01% 2394
2019
Q2 		$67K Buy
17,385
+5,049
+41% +$22.3K ﹤0.01% 2866
2019
Q1 		$47K Sell
12,336
-399
-3% -$1.41K ﹤0.01% 2887
2018
Q4 		$30K Sell
12,735
-97
-0.8% -$480 ﹤0.01% 2981
2018
Q3 		$80K Buy
12,832
+510
+4% +$2.94K ﹤0.01% 2935
2018
Q2 		$56K Buy
+12,322
New +$61.4K ﹤0.01% 2965

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

American International Group's ADMA Position: Q2 2024 in Review

American International Group sold out of ADMA Biologics (ADMA) in Q2 2024, closing a stake of 105,057 shares — an estimated $693K sold.

American International Group first reported a position in ADMA in Q2 2018 and held it in 20 quarters. The position peaked at $693K in Q1 2024. 252 funds tracked by Wall St. Rank hold ADMA as of Q2 2024.

  • American International Group reported no remaining ADMA Biologics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 105,057 ADMA Biologics shares in Q2 2024, an estimated $693K.
  • American International Group first reported a position in ADMA Biologics in Q2 2018 and held it in 20 quarters.
  • American International Group's ADMA Biologics position peaked at $693K in Q1 2024.
  • 252 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.